Revolutionizing Therapies for Aging with Tech-Driven Innovation

At Cerys Bio, we harness the power of technology and AI to make gene therapies faster, affordable, and accessible – driving the future of health and longevity

Technology Driven

Using AI and software to streamline AAV therapy development, time from research to market can be dramatically reduced. Automated workflows and predictive algorithms to help identify optimal treatment strategies efficiently.

Science-First Approach

Our work aims to unlock the full potential of AAV technologies to target age-related diseases at their root by integrating the latest developments in gene therapy and molecular biology to pioneer innovative solutions for aging and collaborating with leading scientists and institutions to ensure our therapies are built on solid, peer-reviewed science.

Accessibility and Customization

Our goal is to make gene therapies not just effective but also affordable and accessible for all by designing flexible, customizable solutions to meet diverse patient needs and clinical settings.



Our objective

At Cerys Bio, we are on a mission to revolutionize the way the world approaches aging. Our focus is on developing cutting-edge AAV (Adeno-Associated Virus) therapies that target the underlying causes of age-related diseases, with the goal of extending healthy lifespans. What sets us apart is our commitment to using advanced technology and AI-driven processes to dramatically streamline the development and delivery of gene therapies. By integrating software solutions and predictive analytics into every phase of our workflow, we aim to reduce time-to-market, lower costs, and offer more personalized treatments tailored to individual needs. We believe that innovation is key to unlocking the potential of gene therapy. At Cerys Bio, our AI-powered tools help us identify the most effective therapeutic pathways quickly and efficiently, enabling us to develop therapies that are not only cutting-edge but also practical and scalable. Our vision extends beyond science—we aim to democratize access to advanced treatments, making them affordable and easily customizable for a wide range of patient scenarios. We understand that the future of healthcare lies not just in groundbreaking discoveries but in ensuring those discoveries reach the people who need them most. Cerys Bio is not just building therapies; we are building a future where technology accelerates health breakthroughs and where longer, healthier lives are within everyone’s reach. As we begin our journey, we are actively seeking partnerships with visionary investors who share our passion for redefining what’s possible in healthcare. With your support, we aim to push the boundaries of science, bringing to life therapies that will shape the future of aging and redefine human longevity. Our objective is simple but ambitious: to leverage technology and AI to be at the forefront of gene therapy development for aging. Through smart, innovative solutions, we aspire to deliver affordable, efficient, and customizable therapies that transform lives and inspire a new era of healthcare.